Cleveland Medical Center

11100 Euclid Avenue
Cleveland, Ohio 44106

We've found

2 trials

at this facility

Long Term Safety Study of Amifampridine Phosphate in MuSK-MG (Muscle Specific Tyrosine Kinase Myasthenia Gravis)

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Cleveland, OH

Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Cleveland, OH

Use our guide to learn which trials are right for you!